RhumbLine Advisers’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Buy |
42,168
+3,393
| +9% | +$17.9K | ﹤0.01% | 3172 |
|
|
2025
Q1 | $316K | Buy |
38,775
+3,448
| +10% | +$28.1K | ﹤0.01% | 2855 |
|
|
2024
Q4 | $452K | Buy |
35,327
+939
| +3% | +$12K | ﹤0.01% | 2733 |
|
|
2024
Q3 | $369K | Sell |
34,388
-2,142
| -6% | -$23K | ﹤0.01% | 2908 |
|
|
2024
Q2 | $289K | Buy |
36,530
+4,463
| +14% | +$35.3K | ﹤0.01% | 3023 |
|
|
2024
Q1 | $514K | Buy |
32,067
+1,043
| +3% | +$16.7K | ﹤0.01% | 2657 |
|
|
2023
Q4 | $426K | Sell |
31,024
-101
| -0.3% | -$1.39K | ﹤0.01% | 2762 |
|
|
2023
Q3 | $455K | Buy |
31,125
+4,096
| +15% | +$59.8K | ﹤0.01% | 2666 |
|
|
2023
Q2 | $460K | Buy |
+27,029
| New | +$460K | ﹤0.01% | 2740 |
|
|
2022
Q2 | – | Sell |
-22,913
| Closed | -$194K | – | 3209 |
|
|
2022
Q1 | $194K | Buy |
22,913
+4,326
| +23% | +$36.6K | ﹤0.01% | 2763 |
|
|
2021
Q4 | $223K | Sell |
18,587
-420
| -2% | -$5.04K | ﹤0.01% | 2807 |
|
|
2021
Q3 | $337K | Buy |
19,007
+1,096
| +6% | +$19.4K | ﹤0.01% | 2717 |
|
|
2021
Q2 | $368K | Buy |
+17,911
| New | +$368K | ﹤0.01% | 2702 |
|